# Abvc Biopharma, Inc.: Form 8-K/A, filed May 2, 2025

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K/A
- Filed: 2025-05-02
- Accepted by EDGAR: May 2, 2025, 16:30 ET
- Period: 2025-04-15
- Accession: 0001213900-25-039184
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025039184/ea024046901-8ka_abvcbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390025039184/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390025039184/ea024046901-8ka_abvcbio.htm

Filed May 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-039184. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
